Patents Assigned to STI PHARMA, LLC
  • Publication number: 20220047505
    Abstract: The present disclosure provides a once-daily water-soluble pharmaceutically active formulation for oral administration. In certain embodiments, the composition comprises a watersoluble pharmaceutically active organic compound incorporated into a small particulate, each particulate having a core of the water-soluble pharmaceutically active organic compound or an acceptable salt thereof in reversible association with a pharmaceutically acceptable drug-binding polymer. The core of the composition being surrounded by an insoluble water permeable membrane that is capable of delaying the dissolution of the pharmaceutically active compound therewithin and providing for extended release of the pharmaceutically active compound.
    Type: Application
    Filed: October 29, 2021
    Publication date: February 17, 2022
    Applicant: STI Pharma, LLC
    Inventors: David F. COUNTS, Donald P. COX, Anup K. DAM, Michael E. STALHAMER
  • Patent number: 11191719
    Abstract: The present disclosure provides a once-daily water-soluble pharmaceutically active formulation for oral administration. In certain embodiments, the composition comprises a watersoluble pharmaceutically active organic compound incorporated into a small particulate, each particulate having a core of the water-soluble pharmaceutically active organic compound or an acceptable salt thereof in reversible association with a pharmaceutically acceptable drug-binding polymer. The core of the composition being surrounded by an insoluble water permeable membrane that is capable of delaying the dissolution of the pharmaceutically active compound therewithin and providing for extended release of the pharmaceutically active compound.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: December 7, 2021
    Assignee: STI Pharma, LLC
    Inventors: David F. Counts, Donald P. Cox, Anup K. Dam, Michael E. Stalhamer
  • Patent number: 10463611
    Abstract: The present disclosure provides a once-daily water-soluble pharmaceutically active formulation for oral administration. In certain embodiments, the composition comprises a water-soluble pharmaceutically active organic compound incorporated into a small particulate, each particulate having a core of the water-soluble pharmaceutically active organic compound or an acceptable salt thereof in reversible association with a pharmaceutically acceptable drug-binding polymer. The core of the composition being surrounded by an insoluble water permeable membrane that is capable of delaying the dissolution of the pharmaceutically active compound therewithin and providing for extended release of the pharmaceutically active compound.
    Type: Grant
    Filed: June 7, 2012
    Date of Patent: November 5, 2019
    Assignee: STI PHARMA, LLC
    Inventors: David F. Counts, Donald P. Cox, Anup K. Dam, Michael E. Stalhamer
  • Publication number: 20140154313
    Abstract: The present disclosure provides a once-daily water-soluble pharmaceutically active formulation for oral administration. In certain embodiments, the composition comprises a watersoluble pharmaceutically active organic compound incorporated into a small particulate, each particulate having a core of the water-soluble pharmaceutically active organic compound or an acceptable salt thereof in reversible association with a pharmaceutically acceptable drug-binding polymer. The core of the composition being surrounded by an insoluble water permeable membrane that is capable of delaying the dissolution of the pharmaceutically active compound therewithin and providing for extended release of the pharmaceutically active compound.
    Type: Application
    Filed: June 7, 2012
    Publication date: June 5, 2014
    Applicant: STI PHARMA, LLC
    Inventors: David F. Counts, Donald P. Cox, Anup K. Dam, Michael E. Stalhamer